Physician profile
Joshua C Sysak
NPI 1346313624
$613.63
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $14.56 · 2021: $77.43 · 2022: $13.01 · 2023: $234 · 2024: $51.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259 · Education: $27.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.65 |
| Education | $27.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $160.24 | 2023 | Tarpeyo |
| Bard Peripheral Vascular, INC. | $159.87 | 2019-2023 | Lutonix Drug Coated Balloon |
| Otsuka America Pharmaceutical, INC. | $61.20 | 2019 | |
| Travere Therapeutics, INC. | $60.11 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $57.44 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $44.20 | 2023-2024 | |
| Akebia Therapeutics INC | $32.04 | 2019-2020 | |
| Aurinia Pharma U.S., INC. | $19.69 | 2021 | |
| Fresenius USA Marketing, INC. | $18.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Sysak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.